M Hamilton. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Adrenergic beta-Antagonists/therapeutic useAortic Diseases/complicationsBenzothiadiazinesBrain Diseases/complicationsCerebrovascular Disorders/prevention & controlCushing Syndrome/complicationsDebrisoquin/therapeutic useDiabetes Mellitus/chemically inducedDiureticsGuanethidine/analogs & derivativesGuanethidine/therapeutic useHeart Failure/prevention & controlHumansHyperaldosteronism/complicationsHypertension/complicationsHypertension/drug therapyHypertension/etiologyHypertension, Malignant/complicationsHypokalemia/chemically inducedKidney Diseases/complicationsMethyldopa/adverse effectsMethyldopa/therapeutic usePulmonary Edema/complicationsSodium Chloride Symporter Inhibitors/adverse effectsSodium Chloride Symporter Inhibitors/therapeutic use
Substances： See more » Adrenergic beta-AntagonistsBenzothiadiazinesDiureticsSodium Chloride Symporter InhibitorsMethyldopaDebrisoquinGuanethidine
Year: 1974 PMID： 4156400
Source DB: PubMed Journal: Practitioner ISSN： 0032-6518